Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study Evaluating the Efficacy and Safety of Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.

NCT07354906 is registered in ClinicalTrials.gov with Groupe français d'étude des Maladies Inflammatoires de loeil as lead sponsor.

NCT NCT07354906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07354906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study Evaluating the Efficacy and Safety of Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.
Lead sponsor
Groupe français d'étude des Maladies Inflammatoires de loeil
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
March 30, 2030
Enrollment
80 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell arteritis (gca)